Quick Takeaways
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC filed SCHEDULE 13G/A for AMICUS THERAPEUTICS, INC. Common Stock (FOLD).
- Disclosed ownership: 3.4%.
- Date of event: 31 Dec 2025.
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC - 31 Dec 2025 SCHEDULE 13G/A Report for AMICUS THERAPEUTICS, INC. Common Stock (FOLD)
- Filing Manager
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
- Reporting Manager
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
- Symbol
- FOLD
- Shares outstanding
- 312,579,912 shares
- Disclosed Ownership
- 10,627,717 shares
- Ownership
- 3.4%
- Form type
- SCHEDULE 13G/A
- Filing time
- 09 Feb 2026, 15:18:10 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 12 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC disclosed 3.4% ownership in AMICUS THERAPEUTICS, INC. Common Stock (FOLD) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 12 Nov 2025.
- Current filing was accepted on 09 Feb 2026, 15:18.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 3.4% | 10,627,717 | 10,321,526 | 0 | Telmo Martins | Chief Compliance Officer |